| Primary |
| Hormone Replacement Therapy |
25.0% |
| Menopause |
20.0% |
| Vitamin Supplementation |
15.0% |
| Hypertension |
10.0% |
| Hysterectomy |
10.0% |
| Migraine |
10.0% |
| Oestrogen Replacement Therapy |
10.0% |
|
| Alopecia |
12.5% |
| Cerebrovascular Accident |
6.3% |
| Coeliac Disease |
6.3% |
| Completed Suicide |
6.3% |
| Drug Ineffective |
6.3% |
| Heart Rate Increased |
6.3% |
| Inappropriate Schedule Of Drug Administration |
6.3% |
| Liver Function Test Abnormal |
6.3% |
| Metrorrhagia |
6.3% |
| Pain In Extremity |
6.3% |
| Pharmaceutical Product Complaint |
6.3% |
| Product Quality Issue |
6.3% |
| Pruritus |
6.3% |
| Rash |
6.3% |
| Tremor |
6.3% |
|
| Secondary |
| Hormone Replacement Therapy |
57.0% |
| Menopausal Symptoms |
23.9% |
| Menopause |
5.9% |
| Parkinson's Disease |
3.9% |
| Anxiety |
1.3% |
| Hypertension |
1.1% |
| Vitamin Supplementation |
0.9% |
| Depression |
0.7% |
| Ill-defined Disorder |
0.7% |
| Thyroid Disorder |
0.7% |
| Dementia Alzheimer's Type |
0.6% |
| Migraine |
0.6% |
| Adverse Drug Reaction |
0.4% |
| Analgesia |
0.4% |
| Ear Infection |
0.4% |
| Heart Rate Irregular |
0.4% |
| Hypothyroidism |
0.4% |
| Muscle Relaxant Therapy |
0.4% |
| Oestrogen Replacement Therapy |
0.4% |
| Atrial Fibrillation |
0.2% |
|
| Breast Cancer |
46.0% |
| Breast Cancer Female |
18.3% |
| Breast Cancer Metastatic |
7.9% |
| Progesterone Receptor Assay Positive |
4.0% |
| Tremor |
4.0% |
| Alopecia |
3.2% |
| Uterine Leiomyoma |
2.4% |
| Altered State Of Consciousness |
1.6% |
| Compression Fracture |
1.6% |
| Insomnia |
1.6% |
| Vomiting |
1.6% |
| Weight Increased |
1.6% |
| Akinesia |
0.8% |
| Bradycardia |
0.8% |
| Contralateral Breast Cancer |
0.8% |
| Dizziness |
0.8% |
| Drug Hypersensitivity |
0.8% |
| Hyperthermia Malignant |
0.8% |
| Inappropriate Schedule Of Drug Administration |
0.8% |
| Interstitial Lung Disease |
0.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Drug Use For Unknown Indication |
12.9% |
| Parkinson's Disease |
12.9% |
| Asthma |
7.7% |
| Hypertension |
7.6% |
| Hypersensitivity |
3.8% |
| Depression |
3.6% |
| Pain |
3.4% |
| Coronary Artery Disease |
2.5% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Hormone Replacement Therapy |
2.1% |
| Osteoporosis |
2.1% |
| Back Pain |
1.9% |
| Constipation |
1.8% |
| Insomnia |
1.8% |
| Anxiety |
1.6% |
| Movement Disorder |
1.6% |
| Spinal Compression Fracture |
1.6% |
| Blood Cholesterol Increased |
1.5% |
|
| Weight Increased |
11.1% |
| Renal Failure Acute |
9.9% |
| Parkinsonism |
7.4% |
| Drug Ineffective |
6.2% |
| Vomiting |
6.2% |
| Hallucination, Visual |
4.9% |
| Skin Exfoliation |
4.9% |
| Somnolence |
4.9% |
| Delirium |
3.7% |
| Gastric Ulcer Haemorrhage |
3.7% |
| Hearing Impaired |
3.7% |
| Muscular Weakness |
3.7% |
| Nausea |
3.7% |
| Pneumonia |
3.7% |
| Renal Impairment |
3.7% |
| Thrombosis In Device |
3.7% |
| Urticaria |
3.7% |
| Weight Decreased |
3.7% |
| Withdrawal Syndrome |
3.7% |
| Wound |
3.7% |
|
| Interacting |
| Lung Neoplasm Malignant |
50.0% |
| Product Used For Unknown Indication |
50.0% |
|
| Drug Interaction |
50.0% |
| Parkinsonism |
50.0% |
|